# Irreversible Diabetic Striatopathy in Reversible Diabetes

**Authors:** Subhankar Chatterjee, Alak Pandit, Samya Sengupta, Shambaditya Das, Ritwik Ghosh, Souvik Dubey

PMC · DOI: 10.1210/jcemcr/luaf292 · JCEM Case Reports · 2026-01-06

## TL;DR

A rare neurological condition called diabetic striatopathy occurred in a woman with steroid-induced diabetes and resolved partially after treatment.

## Contribution

This case highlights DS as a potential complication of steroid-induced diabetes and its possible reversal with treatment.

## Key findings

- Diabetic striatopathy occurred in a patient with steroid-induced diabetes and resolved after glucocorticoid withdrawal.
- Neurological symptoms improved with glycemic control and medication, but some deficits remained.
- MRI showed gliotic changes in the striatum following the condition.

## Abstract

Diabetic striatopathy (DS) is a rare neurometabolic complication of poorly controlled diabetes, typically presenting as hemichorea-hemiballismus. It is most often associated with long-standing diabetes but can rarely occur in steroid-induced diabetes. We report the case of a 59-year-old woman with chronic kidney disease and hypertension who developed new-onset diabetes mellitus and right-sided hemichorea following corticosteroid therapy for nonproliferative glomerulopathy. Magnetic resonance imaging (MRI) confirmed DS with hyperintensity in the left lentiform nucleus. Despite initially requiring insulin, her diabetes resolved entirely following glucocorticoid withdrawal. Choreiform movements improved significantly with glycemic control and neuroleptics; however, residual hemichorea persisted. Follow-up MRI revealed gliotic changes in the striatum. This case highlights the importance of recognizing DS as a possible complication of steroid-induced diabetes. Timely identification and glycemic control can reverse both metabolic and neurological complications, although residual deficits may persist.

## Linked entities

- **Chemicals:** insulin (PubChem CID 70678557)
- **Diseases:** diabetes mellitus (MONDO:0005015), chronic kidney disease (MONDO:0005300)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}
- **Diseases:** hypertension (MESH:D006973), complication (MESH:D008107), glomerulopathy (MESH:D007674), Diabetes (MESH:D003920), hemichorea-hemiballismus (MESH:D020820), Choreiform movements (MESH:D002819), neurological complications (MESH:D002493), chronic kidney disease (MESH:D051436)
- **Chemicals:** steroid (MESH:D013256)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12770900/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12770900/full.md

## References

15 references — full list in the complete paper: https://tomesphere.com/paper/PMC12770900/full.md

---
Source: https://tomesphere.com/paper/PMC12770900